Knotus Co Ltd
KOSDAQ:278650
Intrinsic Value
KNOTUS Co. Ltd. engages in the provision of clinical research services. [ Read More ]
The intrinsic value of one Knotus Co Ltd stock under the Base Case scenario is 2 067.63 KRW. Compared to the current market price of 3 295 KRW, Knotus Co Ltd is Overvalued by 37%.
Valuation Backtest
Knotus Co Ltd
Run backtest to discover the historical profit from buying and selling Knotus Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Knotus Co Ltd
Current Assets | 79.4B |
Cash & Short-Term Investments | 70.4B |
Receivables | 6.6B |
Other Current Assets | 2.4B |
Non-Current Assets | 92.3B |
Long-Term Investments | 47.1B |
PP&E | 40.7B |
Intangibles | 1.8B |
Other Non-Current Assets | 2.7B |
Current Liabilities | 64.7B |
Accounts Payable | 1.6B |
Accrued Liabilities | 631.2m |
Short-Term Debt | 1.7B |
Other Current Liabilities | 60.8B |
Non-Current Liabilities | 5.4B |
Long-Term Debt | 2.5B |
Other Non-Current Liabilities | 2.9B |
Earnings Waterfall
Knotus Co Ltd
Revenue
|
52.8B
KRW
|
Cost of Revenue
|
-16.4B
KRW
|
Gross Profit
|
36.4B
KRW
|
Operating Expenses
|
-37.7B
KRW
|
Operating Income
|
-1.3B
KRW
|
Other Expenses
|
1.1B
KRW
|
Net Income
|
-164m
KRW
|
Free Cash Flow Analysis
Knotus Co Ltd
Profitability Score
Profitability Due Diligence
Knotus Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Knotus Co Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Knotus Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Score
Knotus Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Knotus Co Ltd
Shareholder Return
Price
Knotus Co Ltd
Average Annual Return | 7.67% |
Standard Deviation of Annual Returns | 32.86% |
Max Drawdown | -93% |
Market Capitalization | 257.4B KRW |
Shares Outstanding | 85 024 885 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
KNOTUS Co. Ltd. engages in the provision of clinical research services. The company is headquartered in Incheon, Incheon. The company went IPO on 2019-11-27. is a Korea-based company principally engaged in the nonclinical experiment business. Along with subsidiaries, the Company operates its business through three segments. The Nonclinical Contract Research Organization (CRO) Business segment conducts nonclinical experiments on new developed substances such as new drugs, and tests the efficacy and pharmacodynamics of the substances. This segment also provides services including new drug development related equipment, software and analysis of experimental results. The Animal Laboratory Construction Business segment is engaged in the construction and design of animal laboratories and the supply of reagent consumables. The Pet Business segment is engaged in the development of animal medicines and the sale of pet supplies.
Contact
IPO
Employees
Officers
The intrinsic value of one Knotus Co Ltd stock under the Base Case scenario is 2 067.63 KRW.
Compared to the current market price of 3 295 KRW, Knotus Co Ltd is Overvalued by 37%.